Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 27 NIH 8 NETWORK 6 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 Lymphoid 1 Head & Neck 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 164 Prednisone 129 enzalutamide 125 Docetaxel 122 Abiraterone Acetate 94 Nivolumab 92 Gemcitabine 71 Sunitinib 67 atezolizumab 49 Leuprolide 49 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 48 abiraterone 48 Cisplatin 48 Sorafenib 39 radium Ra 223 dichloride 38 Ipilimumab 38 darolutamide 37 apalutamide 37 Carboplatin 37 Prednisolone 33 Everolimus 33 Axitinib 32 avelumab 31 pazopanib 30 cabozantinib 30 Bevacizumab 30 Paclitaxel 29 enfortumab vedotin 28 bicalutamide 28 Cyclophosphamide 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × X-Rays × Genitourinary × Clear all

NCT07581184 2026-05-12

BActinium-1

Aktis Oncology, Inc.

Phase 1 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡